Home / Latest Reports / Rare Diseases Treatment Market

Rare Diseases Treatment Market by Type, Application, End User, Key Players and Regions - Global Industry Analysis & Forecast to 2027

Published On : August 2022 Pages : 158 Category: Pharma & Healthcare Report Code : HC0817674

Request Sample Inquiry Before Buying Request for Customization Check Discount

The global Rare Diseases Treatment Market is valued at USD XX billion in 2021 and is projected to reach USD XX billion by the end of 2027, growing at a CAGR of XX% during the period 2022 to 2027.

The report exhibit detail coverage of Rare Diseases Treatment industry and market trends. The report also analyses present and past market values to forecast potential market through the forecast period between 2017-2022. This research study of Rare Diseases Treatment Market involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.

In addition, the report provides insight into main drivers, challenges, opportunities and risk of the market and strategies of suppliers. Key players are profiled as well. Overall, this report covers the historical situation, present status and the future prospects of the global Rare Diseases Treatment Market for 2017-2027.

Crystal Market Research envisions that the span of the Rare Diseases Treatment Market will develop amid the estimated time frame as the Compound Annual Growth Rate boosts significantly. The objective of the market research report is the current status of the market and in accordance classifies it into a few portions. The report takes into consideration the prime market players in every area from over the globe.

Our research study analyses the size of the global market of Rare Diseases Treatment in primary regions such as North America, South America, Middle East & Africa, Asia Pacific and Europe. It also classifies the Rare Diseases Treatment Market by key manufacturers, region, type and application. Furthermore, this study examines in the status of the market, market share, future trends, growth rate, competitive landscape, opportunities, market driving factors and restraints, and challenges.

To stay updated with the latest technology and functions of the industry, Crystal Market Research regularly performs interviews with several industry experts and visits for its expert research analysts. The data sources include but not limited to reports of company’s, international organizations and governments, MMI market surveys, and related industry news.

This report forecasts revenue growth at global, regional & country levels and provides an analysis on the industry trends in each of the sub-segments from 2017 to 2027. This report has segmented the Rare Diseases Treatment Market on the basis of fabric, product, application, and region:

Competitive Analysis                    

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

  • F. Hoffmann-La Roche Ltd.
  • Pfizer, Inc.
  • PTC Therapeutics
  • AstraZeneca
  • Novartis AG
  • Takeda Pharmaceutical Company
  • Bayer AG
  • AbbVie Inc.
  • Merck & Co. Inc.
  • Bristol Myers Squibb

By Type

  • Biologics
  • Biosimilar
  • Others

By Application

  • Cancer
  • Neurological Conditions
  • Cardiovascular Conditions
  • Musculoskeletal Conditions
  • Hematologic Disorders
  • Infectious Diseases
  • Metabolic Diseases
  • Endocrine Disorders
  • Others

By End User

  • Hospital Pharmacy
  • Specialty Pharmacy
  • Online Pharmacy

By Region

  • North America (US, Canada,Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Mexico, Columbia, Rest of South America)
  • Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Turkey, Rest of MEA)

Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027

Some of the key questions answered by the report are:

  • What was the market size in 2017 and forecast from 2022 to 2027?
  • What will be the industry market growth from 2017 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Table of Contents

1.     Introduction

1.1.  Report Description

1.2.  Research Methodology

1.2.1.     Data Mining

1.2.2.     Market Modeling and Forecasting

1.2.3.     Data Validation

1.2.4.     Industry Analysis

2.     Market Dashboard

3.     Market Overview

3.1.  Introduction

3.1.1.     Market Definition

3.1.2.     Market Segmentation

3.2.  Market Dynamics

3.2.1.     Drivers

3.2.2.     Restraints

3.2.3.     Opportunities

3.2.4.     Challenges

4.     Rare Diseases Treatment Market, By Type

4.1.  Introduction

4.2.  Rare Diseases Treatment Market and Market Growth Rate By Type (2017-2022)

4.3.  Biologics

4.3.1.     Global Biologics Market and Growth Rate (2017-2022)

4.4.  Biosimilar

4.4.1.     Global Biosimilar Market and Growth Rate (2017-2022)

4.5.  Others

4.5.1.     Global Others Market and Growth Rate (2017-2022)

5.     Rare Diseases Treatment Market, By Application

5.1.  Introduction

5.2.  Rare Diseases Treatment Market and Market Growth Rate By Application (2017-2022)

5.3.  Cancer

5.3.1.     Global Cancer Market and Growth Rate (2017-2022)

5.4.  Neurological Conditions

5.4.1.     Global Neurological Conditions Market and Growth Rate (2017-2022)

5.5.  Cardiovascular Conditions

5.5.1.     Global Cardiovascular Conditions Market and Growth Rate (2017-2022)

5.6.  Musculoskeletal Conditions

5.6.1.     Global Musculoskeletal Conditions Market and Growth Rate (2017-2022)

5.7.  Hematologic Disorders

5.7.1.     Global Hematologic Disorders Market and Growth Rate (2017-2022)

5.8.  Infectious Diseases

5.8.1.     Global Infectious Diseases Market and Growth Rate (2017-2022)

5.9.  Metabolic Diseases

5.9.1.     Global Metabolic Diseases Market and Growth Rate (2017-2022)

5.10.  Endocrine Disorders

5.10.1.     Global Endocrine Disorders Market and Growth Rate (2017-2022)

5.11.  Others

5.11.1.     Global Others Market and Growth Rate (2017-2022)

6.     Rare Diseases Treatment Market, By End User

6.1.  Introduction

6.2.  Rare Diseases Treatment Market and Market Growth Rate By End User (2017-2022)

6.3.  Hospital Pharmacy

6.3.1.     Global Hospital Pharmacy Market and Growth Rate (2017-2022)

6.4.  Specialty Pharmacy

6.4.1.     Global Specialty Pharmacy Market and Growth Rate (2017-2022)

6.5.  Online Pharmacy

6.5.1.     Global Online Pharmacy Market and Growth Rate (2017-2022)

7.     Rare Diseases Treatment Market, By Region

7.1.  Introduction

7.2.  Rare Diseases Treatment Market and Growth Rate By Regions

7.2  North America

7.2.1.     North America Rare Diseases Treatment Market and Growth Rate (2017-2022))

7.2.2.     North America Rare Diseases Treatment Market By Type (2017-2022)

7.2.3.     North America Rare Diseases Treatment Market By Application (2017-2022)

7.2.4.     North America Rare Diseases Treatment Market By End User (2017-2022)

7.2.5.     North America Rare Diseases Treatment Market By Country (2017-2022)

7.2.6.     United States

7.2.6.1.United States Rare Diseases Treatment Market and Growth Rate (2017-2022)

7.2.6.2.United States Rare Diseases Treatment Market By Type (2017-2022)

7.2.6.3.United States Rare Diseases Treatment Market By Application (2017-2022)

7.2.6.4.United States Rare Diseases Treatment Market By End User (2017-2022)

7.2.7.     Canada

7.2.7.1.Canada Rare Diseases Treatment Market and Growth Rate (2017-2022)

7.2.7.2.Canada Rare Diseases Treatment Market By Type (2017-2022)

7.2.7.3.Canada Rare Diseases Treatment Market By Application (2017-2022)

7.2.7.4.Canada Rare Diseases Treatment Market By End User (2017-2022)

7.3  Europe

7.3.1.     Europe Rare Diseases Treatment Market and Growth Rate (2017-2022))

7.3.2.     Europe Rare Diseases Treatment Market By Type (2017-2022)

7.3.3.     Europe Rare Diseases Treatment Market By Application (2017-2022)

7.3.4.     Europe Rare Diseases Treatment Market By End User (2017-2022)

7.3.5.     Europe Rare Diseases Treatment Market By Country (2017-2022)

7.3.6.     Germany

7.3.6.1.Germany Rare Diseases Treatment Market and Growth Rate (2017-2022)

7.3.6.2.Germany Rare Diseases Treatment Market By Type (2017-2022)

7.3.6.3.Germany Rare Diseases Treatment Market By Application (2017-2022)

7.3.6.4.Germany Rare Diseases Treatment Market By End User (2017-2022)

7.3.7.     France

7.3.7.1.France Rare Diseases Treatment Market and Growth Rate (2017-2022)

7.3.7.2.France Rare Diseases Treatment Market By Type (2017-2022)

7.3.7.3.France Rare Diseases Treatment Market By Application (2017-2022)

7.3.7.4.France Rare Diseases Treatment Market By End User (2017-2022)

7.3.8.     UK

7.3.8.1.UK Rare Diseases Treatment Market and Growth Rate (2017-2022)

7.3.8.2.UK Rare Diseases Treatment Market By Type (2017-2022)

7.3.8.3.UK Rare Diseases Treatment Market By Application (2017-2022)

7.3.8.4.UK Rare Diseases Treatment Market By End User (2017-2022)

7.3.9.     Russia

7.3.9.1.Russia Rare Diseases Treatment Market and Growth Rate (2017-2022)

7.3.9.2.Russia Rare Diseases Treatment Market By Type (2017-2022)

7.3.9.3.Russia Rare Diseases Treatment Market By Application (2017-2022)

7.3.9.4.Russia Rare Diseases Treatment Market By End User (2017-2022)

7.3.10.     Italy

7.3.10.1.Italy Rare Diseases Treatment Market and Growth Rate (2017-2022)

7.3.10.2.Italy Rare Diseases Treatment Market By Type (2017-2022)

7.3.10.3.Italy Rare Diseases Treatment Market By Application (2017-2022)

7.3.10.4.Italy Rare Diseases Treatment Market By End User (2017-2022)

7.3.11.     Rest of Europe

7.3.11.1.Rest of Europe Rare Diseases Treatment Market and Growth Rate (2017-2022)

7.3.11.2.Rest of Europe Rare Diseases Treatment Market By Type (2017-2022)

7.3.11.3.Rest of Europe Rare Diseases Treatment Market By Application (2017-2022)

7.3.11.4.Rest of Europe Rare Diseases Treatment Market By End User (2017-2022)

7.4  Asia-Pacific

7.4.1.     Asia-Pacific Rare Diseases Treatment Market and Growth Rate (2017-2022))

7.4.2.     Asia-Pacific Rare Diseases Treatment Market By Type (2017-2022)

7.4.3.     Asia-Pacific Rare Diseases Treatment Market By Application (2017-2022)

7.4.4.     Asia-Pacific Rare Diseases Treatment Market By End User (2017-2022)

7.4.5.     Asia-Pacific Rare Diseases Treatment Market By Country (2017-2022)

7.4.6.     China

7.4.6.1.China Rare Diseases Treatment Market and Growth Rate (2017-2022)

7.4.6.2.China Rare Diseases Treatment Market By Type (2017-2022)

7.4.6.3.China Rare Diseases Treatment Market By Application (2017-2022)

7.4.6.4.China Rare Diseases Treatment Market By End User (2017-2022)

7.4.7.     Japan

7.4.7.1.Japan Rare Diseases Treatment Market and Growth Rate (2017-2022)

7.4.7.2.Japan Rare Diseases Treatment Market By Type (2017-2022)

7.4.7.3.Japan Rare Diseases Treatment Market By Application (2017-2022)

7.4.7.4.Japan Rare Diseases Treatment Market By End User (2017-2022)

7.4.8.     Korea

7.4.8.1.Korea Rare Diseases Treatment Market and Growth Rate (2017-2022)

7.4.8.2.Korea Rare Diseases Treatment Market By Type (2017-2022)

7.4.8.3.Korea Rare Diseases Treatment Market By Application (2017-2022)

7.4.8.4.Korea Rare Diseases Treatment Market By End User (2017-2022)

7.4.9.     India

7.4.9.1.India Rare Diseases Treatment Market and Growth Rate (2017-2022)

7.4.9.2.India Rare Diseases Treatment Market By Type (2017-2022)

7.4.9.3.India Rare Diseases Treatment Market By Application (2017-2022)

7.4.9.4.India Rare Diseases Treatment Market By End User (2017-2022)

7.4.10.     Southeast Asia

7.4.10.1.Southeast Asia Rare Diseases Treatment Market and Growth Rate (2017-2022)

7.4.10.2.Southeast Asia Rare Diseases Treatment Market By Type (2017-2022)

7.4.10.3.Southeast Asia Rare Diseases Treatment Market By Application (2017-2022)

7.4.10.4.Southeast Asia Rare Diseases Treatment Market By End User (2017-2022)

7.4.11.     Rest of Asia-Pacific

7.4.11.1.Rest of Asia-Pacific Rare Diseases Treatment Market and Growth Rate (2017-2022)

7.4.11.2.Rest of Asia-Pacific Rare Diseases Treatment Market By Type (2017-2022)

7.4.11.3.Rest of Asia-Pacific Rare Diseases Treatment Market By Application (2017-2022)

7.4.11.4.Rest of Asia-Pacific Rare Diseases Treatment Market By End User (2017-2022)

7.5  South America

7.5.1.     South America Rare Diseases Treatment Market and Growth Rate (2017-2022))

7.5.2.     South America Rare Diseases Treatment Market By Type (2017-2022)

7.5.3.     South America Rare Diseases Treatment Market By Application (2017-2022)

7.5.4.     South America Rare Diseases Treatment Market By End User (2017-2022)

7.5.5.     South America Rare Diseases Treatment Market By Country (2017-2022)

7.5.6.     Brazil

7.5.6.1.Brazil Rare Diseases Treatment Market and Growth Rate (2017-2022)

7.5.6.2.Brazil Rare Diseases Treatment Market By Type (2017-2022)

7.5.6.3.Brazil Rare Diseases Treatment Market By Application (2017-2022)

7.5.6.4.Brazil Rare Diseases Treatment Market By End User (2017-2022)

7.5.7.     Mexico

7.5.7.1.Mexico Rare Diseases Treatment Market and Growth Rate (2017-2022)

7.5.7.2.Mexico Rare Diseases Treatment Market By Type (2017-2022)

7.5.7.3.Mexico Rare Diseases Treatment Market By Application (2017-2022)

7.5.7.4.Mexico Rare Diseases Treatment Market By End User (2017-2022)

7.5.8.     Columbia

7.5.8.1.Columbia Rare Diseases Treatment Market and Growth Rate (2017-2022)

7.5.8.2.Columbia Rare Diseases Treatment Market By Type (2017-2022)

7.5.8.3.Columbia Rare Diseases Treatment Market By Application (2017-2022)

7.5.8.4.Columbia Rare Diseases Treatment Market By End User (2017-2022)

7.5.9.     Rest of South America

7.5.9.1.Rest of South America Rare Diseases Treatment Market and Growth Rate (2017-2022)

7.5.9.2.Rest of South America Rare Diseases Treatment Market By Type (2017-2022)

7.5.9.3.Rest of South America Rare Diseases Treatment Market By Application (2017-2022)

7.5.9.4.Rest of South America Rare Diseases Treatment Market By End User (2017-2022)

7.6  Middle East and Africa

7.6.1.     Middle East and Africa Rare Diseases Treatment Market and Growth Rate (2017-2022))

7.6.2.     Middle East and Africa Rare Diseases Treatment Market By Type (2017-2022)

7.6.3.     Middle East and Africa Rare Diseases Treatment Market By Application (2017-2022)

7.6.4.     Middle East and Africa Rare Diseases Treatment Market By End User (2017-2022)

7.6.5.     Middle East and Africa Rare Diseases Treatment Market By Country (2017-2022)

7.6.6.     Saudi Arabia

7.6.6.1.Saudi Arabia Rare Diseases Treatment Market and Growth Rate (2017-2022)

7.6.6.2.Saudi Arabia Rare Diseases Treatment Market By Type (2017-2022)

7.6.6.3.Saudi Arabia Rare Diseases Treatment Market By Application (2017-2022)

7.6.6.4.Saudi Arabia Rare Diseases Treatment Market By End User (2017-2022)

7.6.7.     United Arab Emirates

7.6.7.1.United Arab Emirates Rare Diseases Treatment Market and Growth Rate (2017-2022)

7.6.7.2.United Arab Emirates Rare Diseases Treatment Market By Type (2017-2022)

7.6.7.3.United Arab Emirates Rare Diseases Treatment Market By Application (2017-2022)

7.6.7.4.United Arab Emirates Rare Diseases Treatment Market By End User (2017-2022)

7.6.8.     South Africa

7.6.8.1.South Africa Rare Diseases Treatment Market and Growth Rate (2017-2022)

7.6.8.2.South Africa Rare Diseases Treatment Market By Type (2017-2022)

7.6.8.3.South Africa Rare Diseases Treatment Market By Application (2017-2022)

7.6.8.4.South Africa Rare Diseases Treatment Market By End User (2017-2022)

7.6.9.     Rest of Middle East and Africa

7.6.9.1.Rest of Middle East and Africa Rare Diseases Treatment Market and Growth Rate (2017-2022)

7.6.9.2.Rest of Middle East and Africa Rare Diseases Treatment Market By Type (2017-2022)

7.6.9.3.Rest of Middle East and Africa Rare Diseases Treatment Market By Application (2017-2022)

7.6.9.4.Rest of Middle East and Africa Rare Diseases Treatment Market By End User (2017-2022)

8.     Company Profiles

8.1.  F. Hoffmann-La Roche Ltd.

8.1.1.     Business Overview

8.1.2.     Service Portfolio

8.1.3.     Strategic Developments

8.1.4.     Financial Overview

8.2.  Pfizer, Inc.

8.2.1.     Business Overview

8.2.2.     Service Portfolio

8.2.3.     Strategic Developments

8.2.4.     Financial Overview

8.3.  PTC Therapeutics

8.3.1.     Business Overview

8.3.2.     Service Portfolio

8.3.3.     Strategic Developments

8.3.4.     Financial Overview

8.4.  AstraZeneca

8.4.1.     Business Overview

8.4.2.     Service Portfolio

8.4.3.     Strategic Developments

8.4.4.     Financial Overview

8.5.  Novartis AG

8.5.1.     Business Overview

8.5.2.     Service Portfolio

8.5.3.     Strategic Developments

8.5.4.     Financial Overview

8.6.  Takeda Pharmaceutical Company

8.6.1.     Business Overview

8.6.2.     Service Portfolio

8.6.3.     Strategic Developments

8.6.4.     Financial Overview

8.7.  Bayer AG

8.7.1.     Business Overview

8.7.2.     Service Portfolio

8.7.3.     Strategic Developments

8.7.4.     Financial Overview

8.8.  AbbVie Inc.

8.8.1.     Business Overview

8.8.2.     Service Portfolio

8.8.3.     Strategic Developments

8.8.4.     Financial Overview

8.9.  Merck & Co. Inc.

8.9.1.     Business Overview

8.9.2.     Service Portfolio

8.9.3.     Strategic Developments

8.9.4.     Financial Overview

8.10.  Bristol Myers Squibb

8.10.1.     Business Overview

8.10.2.     Service Portfolio

8.10.3.     Strategic Developments

8.10.4.     Financial Overview

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources
  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources
  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)
  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*